Experienced in Swallowing Difficulty

Jorgen K. Johansen

Sdr. Boulevard 29, 
Odense C, DK 
Experienced in Swallowing Difficulty
Sdr. Boulevard 29, 
Odense C, DK 
OverviewLocationsClinical Research

Overview

Jorgen Johansen practices in Odense C, Denmark. Johansen is rated as an Experienced expert by MediFind in the treatment of Swallowing Difficulty. Their top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Prostatectomy, and Laryngectomy.

Their clinical research consists of co-authoring 142 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Swallowing Difficulty.

Locations

Sdr. Boulevard 29, Odense C, 5000, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2025
Intervention Type: Procedure, Radiation, Drug
Study Drugs: Cisplatin, Nimorazole
Study Phase: Not Applicable
Phase II Trial of Cetuximab in Combination With Chemotherapy (Carboplatin and Navelbine) for Patients With Platinum-resistant Head and Neck Cancer
Phase II Trial of Cetuximab in Combination With Chemotherapy (Carboplatin and Navelbine) for Patients With Platinum-resistant Head and Neck Cancer
Enrollment Status: Withdrawn
Publish Date: November 02, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

142 Total Publications

Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses.
Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Johansen's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile